Eisenstadt Richard I

CIK 00015158064 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001515806

Recent Transactions

45 trades

Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-31$2.69/sh+4,621→ 45,012 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-30+9,275→ 42,566 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-30$9.80/sh−2,175→ 40,391 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-01-30−9,275→ 27,825 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2024-01-25+163,200→ 163,200 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2024-01-25+58,400→ 58,400 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-12-29$11.25/sh−3,044→ 33,291 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2023-12-29−12,500→ 25,000 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-12-29+12,500→ 36,335 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-07-31$2.81/sh+1,825→ 23,835 total
Purchase
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-03-24$4.31/sh+10,000→ 22,010 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-01-31$10.21/sh+1,172→ 12,010 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2023-01-30+105,000→ 105,000 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2023-01-30+37,100→ 37,100 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2022-12-31−12,500→ 37,500 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-12-31$16.45/sh−3,028→ 10,838 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-12-31+12,500→ 13,866 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-07-31$6.86/sh+1,366→ 1,366 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2021-12-31+50,000→ 50,000 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2021-12-31+150,000→ 150,000 total
Award
AYTU BIOPHARMA, INC$AYTU
Common Shares
2021-03-31+55,000→ 68,734 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−115,000→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−230,276→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−86,167→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−60,230→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−50,000→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−56,250→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Common Stock
2021-03-19−126,245→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−12,500→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−45,000→ 0 total
Tax Payment
Neos Therapeutics, Inc.
Common Stock
2021-03-02$0.84/sh−14,825→ 126,245 total
Tax Payment
Neos Therapeutics, Inc.
Common Stock
2021-03-01$0.88/sh−1,390→ 141,070 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-03-02+115,000→ 115,000 total
Award
Neos Therapeutics, Inc.
Common Stock
2020-03-02+100,000
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2019-03-01+230,276→ 230,276 total
Purchase
Neos Therapeutics, Inc.
Common Stock
2018-12-12$2.16/sh+5,000→ 42,460 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2018-03-01+56,250→ 56,250 total
Award
Neos Therapeutics, Inc.
Common Stock
2018-03-01+18,750→ 37,460 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2017-05-01+45,000→ 45,000 total
Award
Neos Therapeutics, Inc.
Common Stock
2017-05-01+15,000→ 18,710 total
Purchase
Neos Therapeutics, Inc.
Common Stock
2016-08-25$6.82/sh+3,710→ 3,710 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2016-04-01+50,000→ 50,000 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2015-09-01+60,230→ 60,230 total
Award
Ocera Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2012-08-07+40,000→ 40,000 total
Award
Ocera Therapeutics, Inc.
Stock Option (right to buy)
2011-04-19+148,736→ 148,736 total

Companies

Recent Filings

Address

C/O TRANZYME, INC. 4819 EMPEROR BOULEVARD, SUITE 400

DURHAM, NC, 27703

View on SEC.gov